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Plant cell cultures constitute pesticide-free sources for obtaining plant secondary metab-
olites or plant extracts. Additionally, they do not contain any fungal contaminants, my-
cotoxins or heavy metals providing to the consumer potential health beneﬁts and
justifying the development of this technology at an industrial scale. Signiﬁcant production
levels of these secondary metabolites can be obtained through the use of elicitors, which
activate plant defense mechanisms. Resveratrol, a well-known grapevine polyphenolic
compound which possesses potent antioxidant and antiaging activities as well as a pro-
tective action on skin, is a good example of such plant secondary metabolites. Resveratrol
and its oligomeric derivatives are used by several companies of cosmetic products but their
extraction from vine stems and similar vegetal sources remains difﬁcult. Therefore
grapevine cell suspensions could represent interesting systems for the large-scale bio-
production of those compounds. Here we present an update of the methods used for the
production of phytostilbenes by using grapevine cell cultures and the results obtained.
© 2016 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).r é s u m é
Les cultures cellulaires vegetales constituent une source de metabolites secondaires ou
d'extraits vegetaux denues de pesticides. De plus, celles-ci ne contiennent aucun
contaminant fongique, aucune mycotoxine ou metal lourd, ce qui confere au produit une
valeur sante vis-a-vis des consommateurs et justiﬁe le developpement au niveau industriel
de cette technologie. De grandes quantites de ces metabolites secondaires sont obtenues
par l'utilisation d'eliciteurs qui sont capables d'activer les mecanismes de defense des
plantes. Le resveratrol, un polyphenol de la vigne bien connu, qui possede des activites
anti-oxydantes et anti-a^ge de me^me qu'il exerce une action de protection sur la peau,
constitue un exemple de ce type de metabolite. Le resveratrol et ses derives oligomeriques; FW, fresh weight; JA, jasmonic acid; MeJA, methyljasmonate; SA, salicylic acid.
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P. Jeandet et al. / C. R. Chimie 19 (2016) 1062e1070 1063Fig. 1. Chemsont deja utilises par plusieurs compagnies de produits cosmetiques, mais leur extraction a
partir de sarments de vigne ou de sources vegetales similaires demeure difﬁcile. Les
suspensions cellulaires de vigne representent donc des systemes interessants pour la
production en grandes quantites de ces composes. Nous presentons ici une mise au point
sur leurs methodes de bioproduction en cultures cellulaires et les resultats obtenus.
© 2016 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Polyphenol trans-resveratrol (trans-3,5,4'-trihydrox-
ystilbene) is a famous member of the stilbene family as this
compound has been associated with the “French paradox”
(Fig. 1). Its daily consumption, for example, in the form of
red wine [1], has been linked to beneﬁcial effects in
humans [2] and protection against coronary heart diseases
[3]. First isolated from the white hellebore (Veratrum
grandiﬂorum O. Loes) [4], it was then also found in Japanese
knotweed (Polygonum cuspidatum syn. Fallopia japonica)
[5], the current source for its industrial extraction in China.
In grapevine leaves and berries, trans-resveratrol is a phy-
toalexin produced in response to stresses, such as wound-
ing or pathogen attack [6] showing an antifungal activity
against plant pathogens [7e11] or human pathogens [12].
In grapevine stem (wood) resveratrol is produced consti-
tutively and acts as a phytoanticipin. In humans, resveratrol
might play a role in preventing cardiovascular diseases
[13]; it might also provide some protection against certain
types of cancer [14], diabetes [15] and retard some neuro-
degenerative diseases [16]. In metazoans and mice,
resveratrol has been demonstrated to extend lifespan by
acting as a mimic-agent for the caloric restriction-longevity
effect through sirtuin protein activation [17,18]. Nowadays,
the main market for resveratrol is in the nutraceuticalsical structures of some hydrosector using the Polygonum root as a source but some
American companies have focused on grapevine as the raw
material (Longevinex®). In the cosmetics ﬁeld, the grape-
vine seems to be the most suitable raw material for
resveratrol and its derivatives for products such as face
creams [19,20].
The role of resveratrol in skin protection has to be linked
ﬁrst to its well known antioxidant properties. For example,
in a study evaluating the peroxydal scavenging activities of
various wine polyphenolic monomers, resveratrol was
found to be the strongest compound over catechin, epi-
catechin/gallocatechin and gallic acid/ellagic acid [21]. In
the same way, a formulation containing 1% resveratrol
(FAMAR, Athens, Greece) developed for Calidora Skin
Clinics (Seattle, WA) has shown a 17-fold increase in anti-
oxidant potency against a formulation containing 1% of the
coenzyme Q analog idebenone using the ORAC test (Oxy-
gen Radical Absorbance Capacity, Brunswick Laboratories,
Norton, MA), the latter compound being recognized as the
strongest topical antioxidant [22]. The resveratrol skin care
formulation indeed yielded 4845 mmoles vitamin E equiv-
alents/g against 279 for the 1% idebenone-containing
formulation [23]. Another aspect of interest is the poten-
tial role of resveratrol and derivatives as whitening agents
in cosmetology. Tyrosinase (monophenol, dihydrox-
yphenylalanine: oxygen oxidoreductase EC 1.14.18.1) is axystilbene monomers and dimers.
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namely dihydroxyphenylalanine (DOPA), which is known
as the rate-limiting enzyme of melanin anabolism in me-
lanocytes. Melanin provides protection against UV light-
induced photoaging and photocarcinogenesis. It has
indeed been reported that artiﬁcially enhancing melanin
biosynthesis reduced the incidence of skin cancer in mice
[24] and that the frequency of malignant melanoma was
lowered in dark-skinned humans [25]. However, the over-
production and uneven deposition of melanin, which re-
sults in skin spots, can be the cause of esthetic problems.
This justiﬁes the research for cosmeceuticals capable of
reducing or inhibiting melanin synthesis and accumulation
in humans, that is, whitening agents used to decrease hy-
perpigmentation [26]. Resveratrol or analogs have long
been described as potent inhibitors of the tyrosinase [27].
There are some reports of resveratrol activity as an inhib-
itor of that enzyme using either the mushroom or the
human tyrosinase as a model enzyme [26,28e30]. How-
ever, opinions differ as to its mechanism of action on
tyrosinase inhibition. Some studies suggest that resveratrol
itself does not function as an inhibitor of tyrosinase but is
rather oxidized by it [26,28]. The oxidation forms of
resveratrol in turn become true inhibitors of tyrosinase
activity playing the role of “suicide substrates” for this
enzyme [26,28]. Resveratrol was thus suggested to act as a
kcat type inhibitor for tyrosinase [28]. In other studies,
resveratrol was characterized as a direct inhibitor of the
tyrosinase activity of mushroom or humans with an IC50 of
57.05 mg/L on mushroom tyrosinase activity [29] and
0.39 mg/L on human tyrosinase activity [30], respectively.
Whatever its mechanism of action on tyrosinase inhibition,
these results suggest a possible usage of resveratrol as a
tyrosinase and melanogenesis inhibitor as well as a whit-
ening agent. However, if the antioxidant activity of
resveratrol as well as its effects on tyrosinase inhibition are
well demonstrated, other ways that may explain the
resveratrol action on skin protection probably exist. Alto-
gether, these results conﬁrm the potential of resveratrol as
a cosmeceutical.
Beside resveratrol, it is now well known that grapevine
is able to produce a high diversity of molecules belonging
to the stilbene family (Fig. 1). All these molecules are
powerful antioxidants or at least are suspected to be more
active than resveratrol itself but their extraction is rather
difﬁcult, likely explaining why they are not currently sold
by chemical suppliers, except the dehydrodimer
(þ)- 3-viniferin. The biosynthesis of resveratrol is quite
simple, involving four steps from phenylalanine or three
steps from tyrosine as starting molecules, respectively
(Fig. 2). The synthesis of viniferins by peroxydases, on the
other hand, remains incompletely elucidated. The produc-
tion of recombinant resveratrol is now a reality and many
plants, bacteria or yeast [31,32] have been modiﬁed
genetically in order to produce resveratrol for the assess-
ment of its potential role in human health promotion and
plant disease control. However, there is considerable in-
terest in searching sourcing of resveratrol without recom-
binant genetic modiﬁcation. In this context, plant
biotechnology techniques could thus represent a powerful
means for large-scale production of resveratrol and itsderivatives. The use of plants also allows for low cost and
rapid production of biologically active molecules in large
amounts.
Since the 1980s, plant cell cultures have been used
extensively to investigate the production of secondary
metabolites under controlled conditions. The objective was
to prevent intensive cutting and decimation of natural re-
sources. For instance in the case of taxol, a potent anti-
cancer drug isolated from Taxus brevifolia (Paciﬁc yew
tree), it should be noted that a sufﬁcient dosage of this
compound for one patient requires sacriﬁcing two to four
fully grown trees of this species when the bark is used for
extraction. Additionally, the chemical synthesis of taxol is
extremely complex (requiring 35 to 51 steps), with the
highest total yield of the best synthesis of 0.4% [33 and
references therein]. Plant cell cultures thus appear as a
valuable alternative for the production of such a compound
eliminating reliance on yew tree plantations. Moreover,
plant biotechnology techniques avoid unsustainable
extraction processes or chemical synthesis which include
multiple steps and the use of polluting solvents and metal
catalysts. The advantages afforded by in vitro plant cell
culture systems also result from their potential low pro-
duction costs (plant media only contain minerals, sugars
and traces of growth regulators). In contrast, microorgan-
isms need complex and costly fermentation media and
engineering the entire metabolic pathways is needed [34].
Moreover, the axenic culture conditions afforded by plant
cell systems allow one to avoid contaminants such as
pesticides, fungi or heavy metals and offer the possibility
for a continuous metabolite production. Although a basal
production of secondary metabolites does exist in plant cell
systems, elicitation has been shown as the most efﬁcient
way to induce the synthesis or to enhance the yield of
various compounds of pharmaceutical interest such as al-
kaloids, terpenoids, phenolic compounds or heterosides
[35,36]. Two plant cell model systems are currently under
development through the use of undifferentiated cells
(plant cell suspensions) or plant organ cultures (hairy roots
obtained from Agrobacterium rhizogenes). Both culture
systems typically take place in liquid media under aseptic
conditions and are adaptable to their use in large-scale
bioreactors [37]. Thereafter will be described plant cell
systems usable for the production of resveratrol and related
phytostilbenes.
2. General requirements for establishing cell
suspensions for the production of phytostilbenes in
shake ﬂasks
Resveratrol and phytostilbene production has mainly
been achieved using grapevine cell suspensions. To our
knowledge, there is only one report of a resveratrol pro-
duction by cell suspensions of other species, in cotton
(Gossypium hirsutum L.) [38]. Plant cell cultures only require
minerals, vitamins, sugars and minute quantities of growth
regulators [39]. Themedia used for culturing grapevine cells
are mainly the Murashige and Skoog medium [40,41e46],
the Gamborg medium [47,41,48e57] and supplemented in
some cases with vitamins of the Morel medium
[58,41,49,51,54,56,59]. In all experiments, plant growth
Fig. 2. Biosynthesis of resveratrol and derivatives via the phenylalanine/polymalonate pathway. PAL, Phenylalanine ammonia lyase; TAL, Tyrosine ammonia
lyase; C4H, Cinnamate-4-hydroxylase; 4CL, 4-Coenzyme A ligase; STS, Stilbene synthase; PER, Peroxidases; 3-O-GT, 3-Glucosyl-O-transferase; ROMT, Resveratrol-
O-methyl transferase.
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used. Plant cell suspensions are rotary shaken
(100e110 rpm) and maintained in total darkness
[46,50,52e57,59], with a 16 h light/8 h dark and 14 h light/
10 h dark cycle [44,48,49,51] or under continuous ﬂuores-
cent light [41e43,45]. When discontinuous or continuousillumination is used, light can induce the biosynthesis of
pigments such as anthocyanins, or the photoisomerization
of trans-resveratrol to the cis-form, all by-products that will
have to be removed during the puriﬁcation process. Sucrose
is generally added as the carbon source at a concentration of
10 g/L [44], 20 g/L [48,49,51,52,54e56], 30 g/L [46,53,57] or
P. Jeandet et al. / C. R. Chimie 19 (2016) 1062e10701066even 60 g/L [41,42]. In the latter case, such a high sucrose
concentration has been suggested to constitute an osmotic
stress capable of inducing the production of secondary
metabolites [36].3. Use of elicitors for the induction of resveratrol
production in shake ﬂasks
Resveratrol production by grapevine cell systems has
mainly been achieved in Erlenmeyer ﬂasks of 250 mL and
in some cases in small working volumes of 20 mL with or
without elicitors and cell suspensions are also able to
synthesize resveratrol and its glucoside constitutively
[38,41,43,60]. Nonetheless, most described experiments
employed biotic agents, the so-called elicitors [61], for
inducing phytostilbene biosynthesis in plant cell suspen-
sions. Some of the used elicitors are signal molecules
involved in many plant cell signaling pathways [61]. For
instance, jasmonic acid (JA) which is implied in trans-
duction cascades and its derivative, methyljasmonate
(MeJA) have been used as inducers of hydroxystilbene
production in various plant cell culture systems
[42,44e46,51,52,54,55,62e66]. MeJA is indeed known to
trigger overproduction of compounds of medical interest in
cell suspensions: the anti-cancer drugs, taxol (paclitaxel) in
T. brevifolia Paciﬁc yew tree [64] and ginsenoides in Panax
ginseng [65] or the synthesis of rosmarinic acid, a caffeic
acid ester with potent applications for Alzheimer's disease
in Coleus blumei cultures [66]. Unexpectedly, MeJA alone
was found to be a low elicitor of phytostilbene production
in grapevine cell suspensions. Moreover, it was also re-
ported to decrease cell growth, this decrease being asso-
ciated with a 20e60% lower biomass generation rate
despite any effect on cell viability [46,50,54]. MeJA is
generally added at doses ranging from 5 to 100 mM to
grapevine (Vitis vinifera) cell suspensions resulting in low to
moderate synthesis of resveratrol or its glucoside, piceid, in
shake ﬂasks (Table 1). For instance, 10e20 mM MeJA pro-
moted the endogenous production of 24 mg/g FW resvera-
trol [44] and 120 mg/g FW piceid [45] in grapevine cell
suspensions. The best elicting experiments with MeJAwere
obtained in cell suspensions of V. vinifera cv Monastrell
with a resveratrol production of 3.74 mg/g DW using
100 mM MeJA [54] and in those of the cultivar Gamay
Freaux var Teinturier with a piceid production of 840 mg/L
using 10 mM MeJA [42].
Other signaling molecules such as salicylic acid (SA) and
ethylene are also capable of inducing phytostilbene
biosynthesis in grapevine cell suspensions. A hyper-
elicitation of resveratrol production in the order of 2.7 g/L
was obtained upon the addition of 10 mM JA and 500 mM SA
together with a non aromatic resin dedicated to suppress
the toxic effects of SA and JA in V. vinifera cv Gamay Freaux
var Teinturier cells [53]. A high resveratrol production of
2.4 g/L has also been reported in cell suspensions of the
same cultivar combining treatment with a b-glucan, an
Amberlite resin and 10 mM JA [67]. Finally, 1 mM ethylene
combined with 50 mM cyclodextrins (see below) and
100 mM MeJA was shown to induce more than 1.5 g/L
resveratrol in V. vinifera cv Monastrell cell suspensions [68].Resveratrol and its derivatives are not readily soluble in
aequous solutions as well as in cell suspensions. Moreover,
phytostilbenes are subjected to oxidation and aggregation
phenomena. In order to increase the solubility of these
compounds and diminish subsequent degradation of the
synthesized stilbenes, a number of studies have reported
the use of cyclodextrins (CDs) in cell suspension systems
[48e51,54,69,70]. CDs act as chelating agents, constituting
a family of cyclic oligosaccharides composed of a-(1,4)
linked glucopyrannose units [71]. CDs possess a cage-like
supramolecular structure comprising a central hydropho-
bic cavity while the rims of the surrounding walls are hy-
drophilic (Fig. 3). Such a particular molecular architecture
allows the formation of complexes with hydroxystilbenes
increasing the solubility of the latter in cell suspensions and
protecting them from oxidative degradation and aggrega-
tion phenomena [72]. Beside their role as drug carriers, CDs
are also potent elicitors of resveratrol biosynthesis in
grapevine suspensions alone or in combination with MeJA
[48e51,54,68e70,73]. Various methylated b-cyclodextrins
withmethylation degrees ranging from 11 to 14 and used at
50 mM in grapevine cell suspensions were able to induce
high resveratrol levels from 3 g to 5 g/L [69] (Table 1). The
inﬂuence of the genotype on the response to elicitation
with CDs was directly evidenced in the work of Zamboni
et al. [70], the non-vinifera genotypes producing 60e1800
times more phytostilbenes than vinifera genotypes. CDs
tested as elicitors of hydroxystilbene biosynthesis against
MeJA, JA or SA generally showed the strongest activity
(Table 1). Moreover, in contrast to MeJA, they did not affect
cell viability or cell growth [48e50]. CDs possess structural
motifs which resemble the alkyl-derivatized oligosaccha-
rides produced during pectin hydrolysis by fungal patho-
gens [49], thus explaining their eliciting activity on
phytostilbene biosynthesis in plant cell suspension
systems.
The best eliciting conditions for the production of phy-
tostilbenes by cell suspensions consist of the use of meth-
ylated CDs in combination with MeJA. Some studies have
indeed reported the synergistic effect of MeJA and CDs in
their ability to induce namely the biosynthesis of taxol and
related taxanes in cell cultures of Taxus species [74] as well
as the resveratrol bioproduction in grapevine cell suspen-
sions [50,51,54]. Though a weak to moderate extracellular
accumulation of this compound was observed in V. vinifera
cell suspensions of the cv Gamay as a response to 100 mM
MeJA or 50 mM of a methylated CD, respectively 20 mg/L
and 900 mg/L, a high resveratrol production (3.1 g/L) was
obtained with those two elicitors used in combination [51].
In the same way, 50 mM DIMEB ((heptakis [2,6-di-O-
methyl]-b-cyclodextrin) in combination with 100 mMMeJA
induced a 5-fold increase in the resveratrol biosynthesis by
grapevine cell suspensions of the cv Monastrell albino
(365 mg/g DW) as compared to the obtained 68 mg/g DW
in response to the cyclodextrin alone [50]. Recently, coro-
natine, a phytotoxin from Pseudomonas syringae acting as a
mimic molecule of the isoleucine conjugated form of JA
[75] and known for its ability to induce phytoalexin
biosynthesis in rice [76], was shown to stimulate at a
concentration of 1 mM in combination with 50 mM CDs, a
production of around 0.94 g/L resveratrol in cv Monastrell
Table 1
Plant cell systems in shake ﬂasks for the bioproduction of phytostilbenes.
Plant Elicitors Produced stilbenes References
Vitis vinifera cv Gamay Freaux var. Teinturier None 150 mg/L stilbene glucosides [41]
Vitis vinifera cv Gamay Freaux var. Teinturier None 40 mg/L piceids [60]
Vitis vinifera cv Gamay Freaux var. Teinturier None 330 mg/L stilbenes [43]
Gossypium hirsutum None 7.2 mg/g DW t-resveratrol [38]
Vitis vinifera cv Gamay Freaux var. Teinturier MeJA 25 mM 200 mg/L piceids [62]
Vitis vinifera cv Cabernet Sauvignon
Vitis vinifera cv Gamay Freaux var. Teinturier
MeJA 25 mM
MeJA 10 mM
300 mg/L piceids
840 mg/L piceids
[42]
Vitis vinifera cv Gamay Freaux var. Teinturier MeJA (20 mM) 12 mg/g FW resveratrol and
piceids extracellular
120 mg/g FW resveratrol and
piceids Intracellular
[45]
MeJA 20 mM þ 20 g/L sucrose 46 mg/g FW resveratrol and
piceids extracellular
103 mg/g FW resveratrol and
piceids Intracellular
[45]
Vitis vinifera cv Barbera MeJA 10 mM 23.94 mg/g DW resveratrol
intracellular
7.98 mg/g DW resveratrol
extracellular
[44]
Roostock 41 B MeJA 200 mM 150 mg/L resveratrol [46]
Vitis vinifera cv Monastrell MeJA 5 mM
MeJA 100 mM
798 mg/g DW resveratrol
3.74 mg/g DW resveratrol
[54]
Vitis vinifera cv Alphonse Lavallee MeJA 25 mM þ low energy ultrasounds Viniferins [55]
Vitis vinifera cv Cabernet Sauvignon MeJA 100 mM þ UV-C 2 mg/g DW resveratrol
intracellular
[63]
Vitis vinifera cv Gamay MeJA 100 mM 20 mg/L resveratrol [51]
Vitis vinifera cv Italia MeJA 25 mM
JA 25 mM
0.970 mg/g DW stilbenes
1.023 mg/g DW stilbenes
[52]
Vitis vinifera cv Gamay Freaux var. Teinturier MeJA 10 mM þ SA 500 mM þ resin H2MGL 2667 mg/L resveratrol [53]
Vitis vinifera cv Gamay Freaux var. Teinturier JA 10 mM þ b-glucan þ Amberlite resin 2400 mg/L resveratrol [67]
Vitis vinifera cv Gamay DIMEB 5 mM 148e184 mg/L t-resveratrol [48]
Vitis vinifera cv Monastrell DIMEB 50 mM
HYPROBa50 mM
CAVASOLb 50 mM
>4000 mg/L resveratrol
5000 mg/L resveratrol
5000 mg/L resveratrol
[69]
Vitis vinifera cv Monastrell albino DIMEB 50 mM
HYPROB 50 mM
3400 mg/L resveratrol
3000 mg/L resveratrol
[49]
Vitis vinifera cv
Gamay Rouge
DIMEB 50 mM
HYPROBa 50 mM
3000 mg/L resveratrol
990 mg/L resveratrol
[49]
Vitis vinifera cv Gamay Methylated CDs 50 mM 900 mg/L resveratrol [51]
Vitis vinifera cv Monastrell Undeﬁned CDs 50 mM 600 mg/L resveratrol [54]
V. riparia  V. berlandieri
V. amurensis
Vitis vinifera cv Merzling
Vitis vinifera cv Pinot noir
DIMEB 50 mM
DIMEB 50 mM
DIMEB 50 mM
DIMEB 50 mM
911 mg/L resveratrol
225 mg/L resveratrol
4 mg/L resveratrol
0.5 mg/L resveratrol
[70]
Vitis vinifera cv Monastrell albino DIMEB 50 mM þ MeJA 100 mM
DIMEB 50 mM alone
365 mg/g DW resveratrol
60 mg/g DW resveratrol
[50]
Vitis vinifera cv Gamay Methylated CDs 50 mM þ MeJA 100 mM 3100 mg/L resveratrol [51]
Vitis vinifera cv Monastrell Undeﬁned CDs 50 mM þ MeJA 100 mM 3000 mg/L resveratrol [54]
Vitis vinifera cv Monastrell CAVASOLb 50 mM þ ethylene 1 mM
CAVASOLb 50 mM þ SA 100 mM
CAVASOL b50 mM þ MeJA 100 mMþ ethylene 1 mM
CAVASOLb 50 mM þ MeJA 100 mM þ SA 100 mM
680 mg/L resveratrol
260 mg/L resveratrol
1540 mg/L resveratrol
1040 mg/L resveratrol
[68]
Vitis vinifera cv Monastrell CD 50 mM þ 1 mM coronatine
CD 50 mM þ MeJA
943 mg/L resveratrol
1600 mg/L resveratrol
[59]
Vitis vinifera cv Negramo Coronatine 10 mM 35 mg/L resveratrol
210 mg viniferins/L
[57]
Arachis hypogea
Hairy roots
Sodium acetate 10.2 mM 300e588 mg/g DW of root
Resveratrol extracellular
[80]
Vitis rotundifolia
Hairy roots
MeJA 100 mM <23 mg/g DW Resveratrol
extracellular 1.81 mg/g DW
3-viniferin extracellular
182 mg/g DW Piceids intracellular
[81]
a Cyclodextrin.
b Cyclodextrin.
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Fig. 3. Schematic representation of a cyclodextrin.
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tion was lower than that induced by the combination of
methyljasmonate and a cyclodextrin (1.6 g/L). Ten fold-
higher concentrations of coronatine (10 mM) induced
similar effects on resveratrol biosynthesis in cv Negramaro
grapevine cells and importantly the production of intra-
cellular viniferins [57].
4. Transfer from shake ﬂasks to bioreactors
Transfer of the production of resveratrol by themeans of
biotechnological methods from the laboratory to the in-
dustrial scale relies on the use of cell suspensions in bio-
reactors. Typically the capacity of the bioreactors ranges
from 1 L to over 75,000 L as those used for the large-scale
production of the anti-cancer drug, paclitaxel (taxol) by
Phyton Biotech (www.phytonbiotech.com). Although most
experiments describing resveratrol or phytostilbene syn-
thesis in grapevine cell cultures take place in shake ﬂasks of
20e250 mL with 10e100 mL volumes of cell suspensions
[41e46,48e55,60,62,63,68e70], there are only few reports
of production of those compounds in bioreactors
[43,46,60,77e79]. The main apparatus employed include
classical conﬁgurations such as stirring tanks [43,46,60,77]
and V-shaped or cylindrical bubble columns [78,79]. Be-
sides the question of the bioreactor design, the transferTable 2
Resveratrol production in bioreactors.
Type of bioreactor Working volume
(L)/Grapevine cv
Aeration rate
(vvm)
Maximal
Biomass
(g FW/L)
Stirred bioreactor 15/Gamay Freaux 0.2 269
Stirred bioreactor 2/Roostock 41 B 0.025 546
Stirred bioreactor Not given/Gamay Freaux 0.075e0.15 518
Stirred bioreactor 0.8/Barbera 0.2 L O2/min 40
Bubble column
V-shaped
1.1/Gamay 0.95 246
Stirred bioreactor 1.1/Gamay 2 521
Bubble column
cylindrical
5.8 L  3/Gamay 0.47e0.54 183
a Maximal biomass (g FW/L)  Stilbene production (mg/g FW).from ﬂasks to bioreactors requires the optimization of a lot
of parameters such as 1) the sucrose concentration which
typically ranges from 20 to 60 g/L
[41,42,44,46,48,49,51e57], 2) the speed of agitation in the
case of stirred tanks, 50 rpm [46], 75 rpm [77] and 100 rpm
[60], 3) the density inoculums, and 4) the aeration rates
ﬁxed at 0.075 to 2 vvm [43,78,79]. In our own experiments,
we observed that grapevine cells from the roostock 41 B (V.
vinifera cv Chasselas  V. berlandieri) only tolerated low
aeration and agitation rates, respectively, 0.025 vvm and
50 rpm [46]. This latter remark underlines the fact that
transferring plant cell suspensions from shake ﬂasks to
bioreactors raises several issues which depend on the
cultivated species or even on the used cell line. Although a
constitutive production of the resveratrol glucoside piceid
was already reported in bioreactors with Gamay Freaux cell
suspensions [60] (Table 2), the other experiments were
conducted using elicitors or signaling molecules, mainly,
MeJA and CDs alone or in combination. The maximal stil-
bene production utilizing the combination CDs þ MeJA
expressed as the resveratrol production in mg/g FW
multiplied by the maximal biomass in grams obtained in a
given system can reach the high value of 7.03 g/L resvera-
trol in cell suspensions of the variety Gamay in a stirred
tank [78], 3.3 g/L in a V-shaped bubble column [78] and 6 g/
L in a bubble column cylindrical with a three cycle-one
stage culture system [79]. Here again a synergistic elicit-
ing effect between CDs and MeJA was observed as the
combination of these two elicitors resulted in a 4e6-fold
increase in the resveratrol production (Table 2). The
quantities of resveratrol recovered in bioreactors are thus
in the same order, a few grams per liter, as those obtained in
shake ﬂasks using the best eliciting combinations
(CDs þ MeJA). Chitosan, which is a b-1,4-linked N-glucos-
amine polymer of the cell wall of numerous phytopatho-
genic fungi, was also found to induce the bioproduction
though low of phytostilbenes, reaching 48 mg/L, in liquid
cultures of V. vinifera cv Barbera petiole cells in a 1L-
bioreactor at a concentration of 50 mg/L [77].5. Resveratrol production in hairy roots
Hairy root cultures have also been used for stilbene
production. This valuable system for the production of
plant secondary metabolites [36] is obtained through theProduced stilbenes/Elicitor References
30 mg/L piceidsa None [60]
209 mg/L resveratrol/MeJa [46]
280 mg/L stilbene monomersa/None [43]
48 mg/L resveratrol, piceid resveratrolosidea/Chitosan [77]
3.3 g/L resveratrola/CDs þ MeJA 0.5 g g/L resveratrola/CDs [78]
7 g/L resveratrola/MeJA þ CDs 1.6 g/L resveratrola/CDs [78]
6 g/L resveratrola/MeJA þ CDs [79]
P. Jeandet et al. / C. R. Chimie 19 (2016) 1062e1070 1069transformation of plant tissues by transferring the bacterial
plasmid Ri T-DNA from A. rhizogenes, which causes a ge-
netic modiﬁcation leading to the development of roots.
These roots are able to grow in liquid media and produce
secondary metabolites. For the production of resveratrol,
hairy root cultures of peanut (Arachis hypogea) were eli-
cited with sodium acetate (10.2 mM) leading to a low
production of extracellular resveratrol (300e588 mg/g DW
of root) (Table 1) [80]. Recently, hairy roots of Muscadine
grape (Vitis rotundifolia Michx.) were obtained in which an
extracellular production of resveratrol (<23 mg/g DW;
<100 nmol/g DW) and 3-viniferin (1.81 mg/g DW; <4 nmol/g
DW) as well as an intracellular production of piceids of
182 mg/g DW (467 nmol/g DW) following elicitation by
100 mM MeJA [81] were characterized.
6. Conclusion
Resveratrol is a secondary metabolite which could be of
great interest in the ﬁeld of cosmetology given its antioxi-
dant and anti-aging properties as well as its action on skin
as a whitening agent. There is thus the need for resveratrol
production methods using sustainable sourcing and
without the use of genetically-modiﬁed organisms.
Grapevine cell suspensions have been reported to produce
resveratrol and derivatives, mainly its glucoside piceid and
one of its dimeric compound, 3-viniferin. Most resveratrol
production assays have been conducted in shake ﬂasks and
resveratrol was synthesized constitutively or as a response
to elicitor treatments. Impressive levels of 3e5 g resveratrol
per liter have been observed in shake ﬂasks upon treatment
with methyljasmonate/cyclodextrins in combination or
cyclodextrins alone. One question still remains on how the
transfer from shake ﬂasks to bioreactors can be achieved.
There are only few experiments reporting the transfer of
the resveratrol production from small working volumes
(10e100 mL of plant suspensions) to bioreactors (1e15 L of
plant suspensions). However some results have suggested
that resveratrol production in bioreactors is feasible with
very good yields up to 7 g/L. In most experiments, resver-
atrol was described as being mainly excreted in the extra-
cellular medium, meaning that its puriﬁcation can be easily
performed using apolar solvents such as ethyl acetate.
Piceid remains within the cells and its extraction will need
a greater number of steps. Elucidation of the resveratrol
excretion-mechanisms through the plant cell wall, which
are still not very well known, might thus be of help in
further enhancing its production/secretion in the culture
medium.
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